Altimmune ALT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $97.64M+98.7% | $43.8M+18.5% | $61.28M+94.4% | $183.15M+220% | $49.15M-37.8% | ||
| $233.94M+132% | $229.7M+142% | $149.54M+38.6% | —— | $100.72M-2.3% | ||
| $42K0.0% | $42K0.0% | $42K0.0% | $42K+2.4% | $42K+2.4% | ||
| $1.67M+228% | $1.22M+124% | $845K+97.4% | $321K-24.3% | $507K+65.1% | ||
| $1.43M-51.2% | $2.96M+34.2% | $4.41M+47.0% | $4.4M+36.3% | $2.93M+2.1% | ||
| $334.68M+116% | $278.19M+103% | $216.62M+48.6% | $188.42M+10.1% | $155.26M-17.2% | ||
| $208K-45.8% | $312K-24.5% | $337K-24.4% | $364K-24.6% | $384K-29.4% | ||
| —— | —— | —— | —— | -$681K— | ||
| $746K-53.9% | $1.43M-13.1% | $1.5M-9.9% | $1.56M-6.7% | $1.62M+441% | ||
| $335.63M+113% | $279.93M+101% | $218.45M+47.7% | $190.35M+9.8% | $157.26M-16.5% | ||
| $1.53M+42.1% | $2.72M+1,188% | $4.8M+324% | $851K-68.3% | $1.08M-71.4% | ||
| $265K+8.2% | $256K-8.2% | $247K-21.1% | $239K-30.7% | $245K-51.8% | ||
| $11.32M+15.6% | $15M+43.3% | $12.61M+45.9% | $9.22M-39.2% | $9.8M-13.5% | ||
| $34.51M— | $34.29M— | $14.45M— | $14.33M— | —— | ||
| $5.82M— | $5.75M+7.9% | $5.8M— | $5.43M— | —— | ||
| $51.64M+242% | $55.04M+248% | $32.85M+127% | $28.98M+39.2% | $15.1M-2.1% | ||
| $13K+62.5% | $11K+57.1% | $10K+42.9% | $9K+28.6% | $8K+14.3% | ||
| $961.24M+32.0% | $879.29M+27.5% | $812.73M+20.2% | $769.51M+14.3% | $728.12M+8.9% | ||
| -$672.05M-15.7% | -$649.48M-15.7% | -$622.13M-15.6% | -$603.11M-17.0% | -$580.97M-18.4% | ||
| -$5.22M-4.4% | -$4.93M+0.9% | -$5.02M-3.5% | -$5.04M+2.9% | -$5M+3.1% | ||
| $283.99M+99.8% | $224.89M+82.1% | $185.6M+39.2% | $161.37M+5.8% | $142.16M-17.8% | ||
| $335.63M+113% | $279.93M+101% | $218.45M+47.7% | $190.35M+9.8% | $157.26M-16.5% | ||
| —— | $518K-79.9% | $547K-81.2% | $557K-78.5% | $1.96M-13.9% | ||
| $746K-53.9% | $1.43M-13.1% | $1.5M-9.9% | $1.56M-6.7% | $1.62M+441% | ||
| $746K-53.9% | $1.43M-13.1% | $1.5M-9.9% | $1.56M-6.7% | $1.62M+441% | ||
| $233.94M+132% | $229.7M+142% | $149.54M+38.6% | —— | $100.72M-2.3% | ||
| $746K-53.9% | $1.43M-13.1% | $1.5M-9.9% | $1.56M-6.7% | $1.62M+441% | ||
| $9.79M+12.3% | $12.28M+19.7% | $7.8M+4.0% | $8.37M-32.9% | $8.72M+15.2% | ||
| $34.77M+14,092% | $35.69M+2,023% | $14.69M+729% | $14.57M+683% | $245K-55.6% | ||
| $13K+62.5% | $11K+57.1% | $10K+42.9% | $9K+28.6% | $8K+14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Altimmune's total assets?
- Altimmune (ALT) holds $335.6M in total assets, up 113.4% year over year.
- How much debt does Altimmune have?
- Altimmune carries $34.8M in total debt against $284.0M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Altimmune have?
- Altimmune holds $97.6M in cash and equivalents.
- Can Altimmune cover its short-term obligations?
- Its current ratio is 29.56 — current assets exceed current liabilities.
- Where does Altimmune's balance sheet data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
